Eye diseases in chronic kidney disease: A nationwide longitudinal case-control study in Sweden.
Ballester Dolz Pablo, Ålander Karin, Smedberg Petra, Vihlborg Per, Bryngelsson Ing-Liss, Westerlund Jessica, Makdoumi Karim
AI Summary
Swedish CKD patients had increased risk for most eye diseases, especially retinal disorders and cataracts, often developing earlier. This suggests considering eye screening in CKD patients.
Abstract
Background
Chronic kidney disease (CKD) is a growing health issue that is becoming more prevalent globally, increasing financial cost on healthcare systems. The purpose of this study is to investigate the incidence of eye diseases in patients diagnosed with CKD in Sweden and to evaluate which eye diseases are most likely to develop.
Methods
A longitudinal population-based retrospective case-control study was conducted including all individuals diagnosed with chronic kidney disease during the time period 2001-2019. A total of 19 455 cases and 38 890 controls were included. For each case, two controls were matched with the same sex, age, and county of residence.
Results
CKD patients had a significantly higher risk of contracting any eye disease compared to individuals without kidney disease HR 1.73 (CI 1.67-1.79), with an elevated risk for all blocks of diagnoses except for glaucoma HR 0.95 (CI 0.85-1.06). However, this condition developed earlier in cases than in controls. Subanalyses showed an increased risk for chronic eye disease patients to develop cataract HR 1.70 (CI 1.63-1.78), other retinal disorders HR 1.86 (CI 1.72-2.02), and retinal vascular occlusions HR 2.08 (CI 1.73-2.51). In general, diagnosis of an eye disease occurred earlier in cases than controls.
Conclusions
The results from this study suggest that CKD patients have an increased risk to develop eye disease. Ocular disease seems to develop considerably earlier in CKD, even without staging the severity of the disease, with particularly high risk of developing retinal diseases and cataracts. Screening for eye disease in CKD should be considered.
MeSH Terms
Shields Classification
Key Concepts4
Patients with chronic kidney disease (CKD) had a significantly higher risk of contracting any eye disease compared to individuals without kidney disease (HR 1.73, CI 1.67-1.79) in a longitudinal population-based retrospective case-control study conducted in Sweden, including 19,455 CKD cases and 38,890 matched controls.
In a longitudinal population-based retrospective case-control study conducted in Sweden, including 19,455 CKD cases and 38,890 matched controls, chronic kidney disease (CKD) patients showed an elevated risk for all blocks of eye disease diagnoses except for glaucoma (HR 0.95, CI 0.85-1.06).
In a longitudinal population-based retrospective case-control study conducted in Sweden, including 19,455 CKD cases and 38,890 matched controls, subanalyses showed an increased risk for chronic kidney disease patients to develop cataract (HR 1.70, CI 1.63-1.78), other retinal disorders (HR 1.86, CI 1.72-2.02), and retinal vascular occlusions (HR 2.08, CI 1.73-2.51).
In a longitudinal population-based retrospective case-control study conducted in Sweden, including 19,455 CKD cases and 38,890 matched controls, diagnosis of an eye disease occurred earlier in chronic kidney disease cases than in controls.
Related Articles5
Treatment modalities and trends for hospitalized patients with neovascular glaucoma: A retrospective study of 10 years.
Retrospective StudyThe Burden and Clinical Features of Neovascular Glaucoma in a Major Tertiary Care Center in China.
Cohort StudyAssociation of Primary Open-Angle Glaucoma with Diabetic Retinopathy among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study.
Cohort StudyRisk of Glaucoma after Pars Plana Vitrectomy in a Large Federated Health Record Network.
Cohort StudyImproving the Identification of Diabetic Retinopathy and Related Conditions in the Electronic Health Record Using Natural Language Processing Methods.
Observational StudyIs this article assigned to the wrong chapter(s)? Let us know.